Eterna Therapeutics
ERNA
#10111
Rank
S$12.97 M
Marketcap
$0.25
Share price
3.88%
Change (1 day)
-91.99%
Change (1 year)

Operating Margin for Eterna Therapeutics (ERNA)

Operating Margin as of April 2025 (TTM): -6,487.45%

According to Eterna Therapeutics's latest financial reports and stock price the company's current Operating Margin is -6,487.45%. At the end of 2024 the company had an Operating Margin of -7,647.59%.

Operating Margin history for Eterna Therapeutics from 2024 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-7,647.59%-76%
2023-31,869.12%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-4.61%-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-226.73%-96.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-467.67%-92.79%๐Ÿ‡บ๐Ÿ‡ธ USA
15.12%-100.23%๐Ÿ‡ซ๐Ÿ‡ท France
16.02%-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-156.78%-97.58%๐Ÿ‡ฆ๐Ÿ‡บ Australia
-7.76%-99.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.